![Scott Daniel Cormack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Daniel Cormack
Director/Miembro de la Junta en PC-TRiADD .
Cargos activos de Scott Daniel Cormack
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PC-TRiADD
![]() PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - | - |
Vancouver General Hospital | Corporate Officer/Principal | - | - |
Novelogics Biotechnology, Inc.
![]() Novelogics Biotechnology, Inc. BiotechnologyHealth Technology Novelogics Biotechnology, Inc. is a pre-clinical stage biotech company based in Vancouver, Canada, that is developing innovative antibody immunotherapies for cancer using a novel "interceptor" approach. Novelogics aims to revolutionize cancer treatment with its innovative solution that acts as an "interceptor" of unattached immunosuppressive proteins that have the capacity to shut down critical cancer-killing immune cells. The Canadian company is seeking staged investments and/or partnerships to advance its program. The company was founded by Wayne Cheney and Elaine Allison, with Allison serving as CEO since incorporation. | Director/Miembro de la Junta | - | - |
Historial de carrera de Scott Daniel Cormack
Antiguos cargos conocidos de Scott Daniel Cormack.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Director/Miembro de la Junta | 01/08/2008 | 11/05/2021 |
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Director/Miembro de la Junta | 01/05/2000 | 01/08/2017 |
Director Ejecutivo | 01/08/2008 | 01/08/2017 | |
Director Financiero/CFO | 01/05/2000 | 11/08/2014 | |
Fundador | 01/10/1991 | 01/08/2017 | |
Presidente | 01/08/2008 | 01/08/2017 | |
Secretario Corporativo | 01/05/2000 | 01/08/2017 | |
Treasurer | 01/05/2000 | 01/08/2017 | |
AURINIA PHARMACEUTICALS INC. | Director/Miembro de la Junta | 01/01/2012 | 01/01/2014 |
LifeSciences British Columbia
![]() LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | 02/10/2008 | 02/10/2008 |
OncoGenex Technologies, Inc.
![]() OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Director Ejecutivo | 01/05/2000 | 22/08/2008 |
Fundador | 22/08/2008 | 22/08/2008 | |
Presidente | - | 22/08/2008 | |
Milestone Medica Corp. | Corporate Officer/Principal | 02/01/2001 | 02/01/2001 |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░ ░░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Scott Daniel Cormack.
University of Alberta | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 13 |
Estados Unidos | 4 |
Operativa
Director/Board Member | 7 |
President | 4 |
Chief Executive Officer | 3 |
Sectorial
Health Technology | 8 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
NeuroSpheres Ltd. | |
OncoGenex Technologies, Inc.
![]() OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
Milestone Medica Corp. | Finance |
LifeSciences British Columbia
![]() LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Vancouver General Hospital | |
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
Salpep Biotechnology, Inc. | |
Vetrepharm, Inc. | |
For Tomorrow | |
Fe Pharmaceuticals (Canada), Inc.
![]() Fe Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Fe Pharmaceuticals (Canada), Inc. operates as a research institution. It offers indication & treatment challenge, technical innovation and market services. The company was founded by William M. Cheliak and Bruce Holbein and is headquartered in Halifax, Canada. | Health Technology |
PC-TRiADD
![]() PC-TRiADD Miscellaneous Commercial ServicesCommercial Services PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada. | Commercial Services |
Novelogics Biotechnology, Inc.
![]() Novelogics Biotechnology, Inc. BiotechnologyHealth Technology Novelogics Biotechnology, Inc. is a pre-clinical stage biotech company based in Vancouver, Canada, that is developing innovative antibody immunotherapies for cancer using a novel "interceptor" approach. Novelogics aims to revolutionize cancer treatment with its innovative solution that acts as an "interceptor" of unattached immunosuppressive proteins that have the capacity to shut down critical cancer-killing immune cells. The Canadian company is seeking staged investments and/or partnerships to advance its program. The company was founded by Wayne Cheney and Elaine Allison, with Allison serving as CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Daniel Cormack
- Experiencia